Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Capital Employed: 2010-2024

Historic Return on Capital Employed for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -0.43%.

  • China Pharma Holdings' Return on Capital Employed rose 11.00% to -0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.40%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.43% for FY2024, which is 16.00% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Return on Capital Employed is -0.43%, which was down 61.20% from -0.27% recorded in FY2023.
  • China Pharma Holdings' 5-year Return on Capital Employed high stood at -0.25% for FY2020, and its period low was -0.47% during FY2022.
  • Over the past 3 years, China Pharma Holdings' median Return on Capital Employed value was -0.43% (recorded in 2024), while the average stood at -0.39%.
  • As far as peak fluctuations go, China Pharma Holdings' Return on Capital Employed soared by 61bps in 2020, and later dropped by 22bps in 2022.
  • Over the past 5 years, China Pharma Holdings' Return on Capital Employed (Yearly) stood at -0.25% in 2020, then remained steady at -0.25% in 2021, then dropped by 22bps to -0.47% in 2022, then grew by 21bps to -0.27% in 2023, then decreased by 16bps to -0.43% in 2024.